文献速递心脏核医学肿瘤 PET/CT

PET分子显像在免疫检查点抑制剂相关心肌炎中的临床应用与研究进展

Clinical application and research advances of positron emission tomography molecular imaging in immune checkpoint inhibitor-associated myocarditis.
PubMed 文献 · J Nucl Cardiol · 2026-07-03

本文综述PET分子显像在免疫检查点抑制剂(ICI)相关心肌炎临床管理中的应用价值与研究进展。ICI相关心肌炎罕见但可能致命,临床表现高度异质且隐匿进展,常规诊断方法难以早期准确识别。PET通过靶向特定病理生理过程,有望实现无创诊断与监测,新型探针与成像技术进展可能进一步提升其表征关键机制的能力。

要点

  • ICI相关心肌炎罕见但可能致命,早期诊断与风险分层至关重要。
  • 常规诊断方法难以应对其高度异质和隐匿进展的临床表现。
  • PET分子显像靶向特定病理生理过程,有望用于无创诊断与监测。

核心结论

  • PET分子显像在ICI相关心肌炎的临床管理中具有应用价值,新型探针与成像技术进展可能提升其表征关键机制的能力。

研究设计与样本

  • 本文基于当前临床证据与研究结果,综述PET分子显像在ICI相关心肌炎临床管理中的应用价值并总结近期研究进展。

主要发现

  • ICI相关心肌炎罕见但可能致命,严重影响患者长期预后。
  • 该病临床表现高度异质且隐匿进展,常规诊断方法难以实现及时准确检测。
  • PET分子显像通过靶向特定病理生理过程,有望实现无创诊断与监测。

临床怎么用

  • PET分子显像可为ICI相关心肌炎的早期精准干预提供独特影像窗口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immunotherapy, represented by immune checkpoint inhibitors (ICIs), has revolutionized cancer treatment paradigms yet has simultaneously posed significant challenges due to various immune-related adverse events. Among these, ICI-associated myocarditis-a rare but potentially fatal complication that severely impacts long-term patient prognosis-makes early diagnosis and risk stratification crucial. However, its highly heterogeneous and insidiously progressive clinical presentation challenges timely and accurate detection by conventional diagnostic methods, highlighting an urgent clinical need for more effective approaches. Positron emission tomography (PET) molecular imaging, by targeting specific pathophysiological processes, holds great potential for the noninvasive diagnosis and monitoring of this disease. Ongoing advances in novel probes and imaging technologies may further improve the capability of PET to characterize key mechanisms of ICI-associated myocarditis, providing a unique imaging window for early and precise intervention. Based on current clinical evidence and research findings, this article elaborates on the application value of PET molecular imaging in the clinical management of ICI-associated myocarditis and summarizes recent research progress, aiming to inform future clinical practice and research.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Lv Y, Zheng D, Zhou Z, et al. Clinical application and research advances of positron emission tomography molecular imaging in immune checkpoint inhibitor-associated myocarditis. J Nucl Cardiol. 2026. PMID: 42398696. doi:10.1016/j.nuclcard.2026.102798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。